GlobeNewswire Inc | Sep 16, 2020 08:13AM EDT

September 16, 2020

RICHLAND, Wash., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23 at 1:40 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.

A live webcast of the presentation will be available on Isorays Investor Relations section of the Companys website at https://isoray.com/investors/presentations/. An on-demand replay of the presentation will be available shortly after the conclusion of the presentation on the Investor Relations section of the website and will be available for 90 days.

About IsorayIsoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.

Contact: Investor Relations: Mark Levin (501) 255-1910Media and Public Relations: Sharon Schultz (302) 539-3747